<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Plasma protein <z:mpath ids='MPATH_73'>growth arrest</z:mpath>-specific 6 (Gas6) is important to the inflammatory process and is involved in the development of diabetic renal and vascular complications </plain></SENT>
<SENT sid="1" pm="."><plain>We set out to determine whether plasma Gas6 levels are associated with altered <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, insulin sensitivity, <z:mp ids='MP_0001845'>inflammation</z:mp>, and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 278 adults, including 96 with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT), 82 with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT), and 100 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> were recruited </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma Gas6 concentration and biochemical, proinflammatory, and endothelial variables were determined </plain></SENT>
<SENT sid="4" pm="."><plain>Insulin sensitivity was examined by homeostasis model assessment </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Plasma Gas6 concentration was significantly lower among patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> compared with subjects with NGT (P &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>The plasma Gas6 value was inversely correlated with fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha, interleukin (IL)-6, and vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (VCAM)-1 </plain></SENT>
<SENT sid="7" pm="."><plain>In multivariate logistic regression analysis, after adjustment for established <z:mp ids='MP_0002055'>diabetes</z:mp> risk factors, higher plasma Gas6 concentrations were significantly associated with a decreased risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, the association became slightly stronger after further adjustment for TNF-alpha, IL-6, high-sensitive C-reactive protein, E-selectin, intercellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule-1, and VCAM-1 </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Plasma Gas6 is associated with altered <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance, <z:mp ids='MP_0001845'>inflammation</z:mp>, and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>It also may represent a novel independent risk factor of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and a potential surrogate marker of <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> </plain></SENT>
</text></document>